Wolff Wiese Magana’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
844
+766
| +982% | +$96.3K | 0.07% | 141 |
|
|
2025
Q1 | $8.63K | Sell |
78
-25
| -24% | -$2.77K | 0.01% | 437 |
|
|
2024
Q4 | $14.1K | Hold |
103
| – | – | 0.01% | 357 |
|
|
2024
Q3 | $11.9K | Buy |
103
+56
| +119% | +$6.45K | 0.01% | 411 |
|
|
2024
Q2 | $6.47K | Sell |
47
-26
| -36% | -$3.58K | 0.01% | 385 |
|
|
2024
Q1 | $10.1K | Buy |
73
+26
| +55% | +$3.59K | 0.01% | 296 |
|
|
2023
Q4 | $6.19K | Hold |
47
| – | – | 0.01% | 350 |
|
|
2023
Q3 | $5.29K | Sell |
47
-100
| -68% | -$11.3K | ﹤0.01% | 428 |
|
|
2023
Q2 | $13.9K | Hold |
147
| – | – | 0.01% | 313 |
|
|
2023
Q1 | $14.9K | Hold |
147
| – | – | 0.01% | 308 |
|
|
2022
Q4 | $17.6K | Hold |
147
| – | – | 0.02% | 272 |
|
|
2022
Q3 | $16K | Hold |
147
| – | – | 0.01% | 421 |
|
|
2022
Q2 | $14K | Hold |
147
| – | – | 0.01% | 480 |
|
|
2022
Q1 | $14K | Hold |
147
| – | – | 0.01% | 492 |
|
|
2021
Q4 | $13K | Hold |
147
| – | – | 0.01% | 500 |
|
|
2021
Q3 | $14K | Hold |
147
| – | – | 0.01% | 477 |
|
|
2021
Q2 | $14K | Hold |
147
| – | – | 0.01% | 448 |
|
|
2021
Q1 | $14K | Buy |
147
+25
| +20% | +$2.38K | 0.01% | 435 |
|
|
2020
Q4 | $12K | Buy |
+122
| New | +$12K | 0.01% | 423 |
|